Organovo (NASDAQ:ONVO) shares were up 4.5% during mid-day trading on Wednesday . The stock traded as high as $1.75 and last traded at $1.69. Approximately 79,132 shares traded hands during trading, a decline of 92% from the average daily volume of 1,015,418 shares. The stock had previously closed at $1.77.
Several research analysts have issued reports on ONVO shares. Zacks Investment Research upgraded Organovo from a “hold” rating to a “buy” rating and set a $1.25 target price for the company in a research report on Thursday, March 8th. ValuEngine upgraded Organovo from a “strong sell” rating to a “sell” rating in a report on Wednesday, May 2nd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $3.40.
The firm has a market cap of $192.85 million, a PE ratio of -4.46 and a beta of 2.71.
Organovo Company Profile
Organovo Holdings, Inc, an early commercial stage company, designs and creates functional and three-dimensional (3D) human tissues for use in medical research and therapeutic applications. The company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic, and other partners.
Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.